HYPD
Hyperion DeFi, Inc.
NASDAQ: HYPD · HEALTHCARE · BIOTECHNOLOGY
$3.96
-7.04% today
Updated 2026-04-29
Market cap
$47.50M
P/E ratio
—
P/S ratio
58.40x
EPS (TTM)
$-9.40
Dividend yield
—
52W range
$1 – $17
Volume
0.4M
Hyperion DeFi, Inc. (HYPD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.00M | $14.00M | $0.00 | $3787.00 | $57336.00 | $813455.00 |
| Revenue growth (YoY) | — | +600.0% | -100.0% | — | +1414.0% | +1318.8% |
| Cost of revenue | $800000.00 | $1.60M | $0.00 | $16005.00 | $3.93M | $303290.00 |
| Gross profit | $1.20M | $12.40M | $0.00 | $-12218.00 | $-3.87M | $510165.00 |
| Gross margin | 60.0% | 88.6% | — | -322.6% | -6749.5% | 62.7% |
| R&D | $13.36M | $14.85M | $13.38M | $12.98M | $14.46M | $1.91M |
| SG&A | $7.63M | $8.61M | $12.33M | $11.32M | $13.59M | $17.18M |
| Operating income | $-19.79M | $-13.02M | $-26.91M | $-25.41M | $-48.74M | $-18.98M |
| Operating margin | -989.5% | -93.0% | — | -670885.8% | -85004.6% | -2333.4% |
| EBITDA | $-19.69M | $-12.17M | $-26.32M | $-24.11M | $-46.21M | $-18.98M |
| EBITDA margin | -984.7% | -86.9% | — | -636547.1% | -80587.3% | -2333.4% |
| EBIT | $-19.79M | $-12.39M | $-26.63M | $-24.89M | $-47.33M | — |
| Interest expense | $17042.00 | $387756.00 | $1.38M | $2.37M | $2.48M | $1.56M |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-19.77M | $-12.78M | $-28.01M | $-27.26M | $-49.82M | $-45.31M |
| Net income growth (YoY) | — | +35.4% | -119.2% | +2.7% | -82.7% | +9.0% |
| Profit margin | -988.5% | -91.3% | — | -719859.9% | -86888.6% | -5570.6% |